Key facts
- This page summarizes Lou Silverman's Form 4 filing for Insight Molecular Diagnostics Inc. (IMDX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 06 Jul 2026, 20:40.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Tax liability
Additional SEC filing notes
Footnote F1
The reported disposition reflects shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of 35,000 shares of restricted stock units granted to the reporting person on July 1, 2025. The reporting person did not sell any shares. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.